Dolphin Vagal Nerve Stimulator™: Long-haul Symptom Management Made Simple The Dolphin Vagal Nerve Stimulator produces minute microcurrent impulses that gently relax muscles, calm the nervous ...

The company’s flagship product, the Dolphin Vagal Nerve Stimulator (dVNS), is the first medical device authorized by Health Canada to provide relief to people with post-COVID-19 conditions.

Dolphin Vagal Nerve Stimulator (VNS) Kit retails for $749.00 and may be purchased directly on the company's website. SOURCE Dolphin Neurostim ...

"SPARC: Respiratory‐Gated Transcutaneous Vagus Nerve Stimulation Modulates Gastric Function in Functional Dyspepsia." The FASEB Journal (First published: April 20, 2020) DOI: 10.1096/fasebj.2020 ...

The company’s flagship product, the Dolphin Vagal Nerve Stimulator (dVNS), is the first medical device authorized by Health Canada to provide relief to people with post-COVID-19 conditions.

According to the latest research by the company, the global vagus nerve stimulator market is projected to account for over US$ 1.129.5 Mn, in terms of value, by 2028 end.

"SPARC: Respiratory‐Gated Transcutaneous Vagus Nerve Stimulation Modulates Gastric Function in Functional Dyspepsia." The FASEB Journal (First published: April 20, 2020) DOI: 10.1096/fasebj.2020 ...

HOUSTON, Texas — An implanted device that stimulates the vagus nerve has shown promising improvement of arm function in stroke patients in a second small clinical study. While the primary ...

Clinical benefit of vagus nerve stimulation for epilepsy: assessment of randomized controlled trials and prospective non-randomized studies. J Cent Nerv Syst Dis. Published online January 11, 2023 ...